Mclean Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mclean Hospital sits in the top decile of US sponsors by registered trial count (#201 of 15,742 sponsors by registered trial count).
Mclean Hospital: 140 sponsored US clinical trials, 26 recruiting.
Mclean Hospital sponsors 140 registered US clinical trials on ClinicalTrials.gov, 26 of them currently recruiting, and 92 completed. 13 of these trials are in Phase 3-4 (later-stage) and 40 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Major Depressive Disorder, with 9 trials.
Top-decile sponsor footprint
Mclean Hospital ranks in the top decile of sponsors by registered trial count (#201 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
92 of 110 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
140 total, page 3 of 3
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
NCT01148979
Acute Glycine Pharmacodynamic Study
NCT01610011
Nabilone for Cannabis Dependence: A Pilot Study
NCT01347762
Kudzu Treatment for Alcohol Abuse
NCT01596231
Proton MRS Study of SSRI-Zolpidem Interactions
NCT01809626
Treatment Resistant Geriatric Depression in Primary Care
NCT01392287
The Effects of Cranial Electrotherapy Stimulation (CES) on Brain Function, Brain Chemistry and Mood
NCT01860677
Frovatriptan and Menstrual Migraine
NCT01114711
Treximet Migraine Brain Imaging Research Study
NCT01112553
Generalized Anxiety and Seroquel
NCT01066143
An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
NCT01038128
Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals
NCT00158249
Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine Dependence
NCT01292642
Puerarin Effects on Alcohol Drinking
NCT00854724
A Trial of SAMe for Treatment-Resistant Bipolar Depression
NCT00762268
Women's Recovery Group (WRG) Study - A Randomized Controlled Stage II Trial
NCT01318538
The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder
NCT00719706
CoQ10 in Geriatric Bipolar Depression
NCT00720369
Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device
NCT00578383
Transdermal Electroacupuncture for Opioid Detoxification
NCT00742170
Riluzole in the Treatment of Bipolar Depression
NCT00544544
Effects of Pentazocine Versus Lorazepam on Manic Symptoms
NCT00431184
Study of Brain Circuitry in Anxiety Disorders
NCT01849432
Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects
NCT00567034
An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome
NCT00401258
Effect of Uridine on GABA and High Energy Phosphate Levels in Healthy Volunteers
NCT01261260
Prescription Opioid Addiction Treatment Study (POATS)
NCT00316277
An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder
NCT00330655
Lamotrigine Therapy in Geriatric Bipolar Depression
NCT00720473
AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment
NCT00304746
Nicotine Related Brain Activity: The Influence of Smoking History and Blood Nicotine Levels
NCT01588561
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
NCT00125957
Follow-Up Extension to the Family Study of Binge Eating Disorder
NCT00777634
Understanding Brain Reward Responses in Individuals With Major Depressive Disorder
NCT00183755
Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study
NCT00217165
Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder
NCT00634062
Magnetic Resonance Imaging Study of Geriatric Depression
NCT00245557
Low Field Magnetic Stimulation Treatment for Bipolar Depression
NCT00217217
Cytidine and Omega-3 Fatty Acids in Bipolar Disorder
NCT00854737
The Women's Recovery Group Study: Stage I Trial
NCT00230100
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 19 |
| Phase 2 | 21 |
| Phase 3 | 3 |
| Phase 4 | 10 |
Therapeutic Areas
What is open in the Mclean Hospital pipeline
26 recruiting of 140 indexed (19% open); 92 completed (66%).
Phase mix: 13 late (III/IV) vs 40 early (I/II) (early-phase heavy).
Top condition: Major Depressive Disorder (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Mclean Hospital: open-pipeline peers nationwide
Peers matched on 140 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Mclean Hospital sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 140 trials (± recruiting share)
- Case Western Reserve University · 141 trials · 16% recruiting
- Eastern Cooperative Oncology Group · 141 trials · 3% recruiting
- Purdue University · 141 trials · 10% recruiting
- Barbara Ann Karmanos Cancer Institute · 139 trials · 12% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
- University of Missouri-Columbia · 19% recruiting · 291 trials
- Montefiore Medical Center · 19% recruiting · 345 trials
Related
What to do with this Mclean Hospital page
140 registered trials is a research-attention snapshot, not an endorsement of Mclean Hospital or any single study.
- 26 of Mclean Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Major Depressive Disorder is the condition Mclean Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Major Depressive Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Mclean Hospital pipeline card: 140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.